Covishield Update: Serum Institute Stops AstraZeneca Vaccine Production

Serum Institute Request For Emergency Vaccine Use To Be Considered TodayПодробнее

Covid-19: DCGI extends shelf life of Covishield to 9 months from manufacturing dateПодробнее

AstraZeneca Legal Notice To Serum Institute Over Vaccine Delays: SourcesПодробнее

UK Approves Oxford-Astrazeneca's Coronavirus Vaccine, Will Covishield Get Nod In India Soon?Подробнее

Serum Institute Of India To Begin AstraZeneca-Oxford’s COVID-19 Vaccine Trial In IndiaПодробнее

AstraZeneca admits Covid vaccine can cause TTS #shortsonyoutube #covishield #seruminstitute #shortsПодробнее

Serum Institute seeks approval for Oxford COVID Vaccine, Covishield | World News | WION NewsПодробнее

Covishield Update: Serum Institute Stops AstraZeneca Vaccine ProductionПодробнее

Serum Institute Seeks Emergency Clearance In India. What Happens Next? | Big StoryПодробнее

Serum Institute Reduces Price Of Covishield By Rs 100 | Breaking News | India TodayПодробнее

Covid: SII reduces Covishield price, vaccine now at Rs 300 per dose for statesПодробнее

Serum Institute of India Commits COVID-19 Vaccines To Vulnerable | Global Goal: Unite for Our FutureПодробнее

India’s drugs experts approve AstraZeneca, local COVID vaccinesПодробнее

COVID-19: Serum Institute To Produce 10 Crore Covishield Doses By JuneПодробнее

Covishield Vaccine By SII-Astrazeneca Likely To Get Approval, Expert Panel To Meet Today| BreakingПодробнее

Covishield Vaccine By SII-Astrazeneca Likely To Get Approval, Expert Panel To Meet TomorrowПодробнее

Why Oxford-AstraZeneca's Covishield Suits India?Подробнее

Serum Institute of India’s Covishield vaccine passes the quality test at the national laboratoryПодробнее

Serum Institute To Seek Rs 100 Cr In Damages From Virus Vaccine Trial ParticipantПодробнее